Immunome (IMNM) Net Income Growth (1y) (2020 - 2026)
Immunome (IMNM) Net Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 145.96% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | -443.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -443.98% |
| Dec 31, 2025 | 12.21% |
| Sep 30, 2025 | 12.25% |
| Jun 30, 2025 | 18.47% |
| Mar 31, 2025 | 66.09% |
| Dec 31, 2024 | 12.04% |
| Sep 30, 2024 | -633.47% |
| Jun 30, 2024 | -436.47% |
| Mar 31, 2024 | -2,796.50% |
| Dec 31, 2023 | -1,071.79% |
| Sep 30, 2023 | -32.67% |
| Jun 30, 2023 | -49.85% |
| Mar 31, 2023 | 61.11% |
| Dec 31, 2022 | -3.00% |
| Sep 30, 2022 | -54.53% |
| Jun 30, 2022 | 58.81% |
| Mar 31, 2022 | -194.07% |
| Dec 31, 2021 | -89.19% |
| Sep 30, 2021 | 55.40% |
| Jun 30, 2021 | -853.50% |